Veteran investment executive focused on private markets and strategic capital deployment, Nicholas B. Yeomans combines operational finance and deal-sourcing experience across growth and buyout situations. He has overseen portfolio construction, due diligence and LP relations at mid-sized asset managers and family offices, with emphasis on sector workstreams and exit strategy. Known for disciplined valuation and portfolio governance approaches aligned to institutional investors.
Veteran investment executive focused on private markets and strategic capital deployment, Nicholas B. Yeomans combines operational finance and deal-sourcing experience across growth and buyout situations. He has overseen portfolio construction, due diligence and LP relations at mid-sized asset managers and family offices, with emphasis on sector workstreams and exit strategy. Known for disciplined valuation and portfolio governance approaches aligned to institutional investors.
Seasoned private-markets investor who prioritizes disciplined, valuation-driven deployment across growth and buyout situations, balancing active portfolio construction with clear exit pathways. Emphasizes sector-focused sourcing and deep due diligence to identify asymmetric risk/reward, using operational finance insights to optimize capital structure and drive EBITDA expansion. Prefers concentrated conviction positions with staged capital tranches, LP-aligned governance, and defined downside protections. Time horizon is multi-year, value-creation oriented; decision-making blends quantitative valuation thresholds with operational playbooks and scenario-based stress testing.
Seasoned private-markets investor who prioritizes disciplined, valuation-driven deployment across growth and buyout situations, balancing active portfolio construction with clear exit pathways. Emphasizes sector-focused sourcing and deep due diligence to identify asymmetric risk/reward, using operational finance insights to optimize capital structure and drive EBITDA expansion. Prefers concentrated conviction positions with staged capital tranches, LP-aligned governance, and defined downside protections. Time horizon is multi-year, value-creation oriented; decision-making blends quantitative valuation thresholds with operational playbooks and scenario-based stress testing.
| Trades 779 | Longs Won 554/779 71% | Profit Factor 7.43 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $524,250.74 |
| Average Win $207,047.99 | Best Trade (Aug 20) $6.22M | Sharpe Ratio -13.44 |
| Average Loss -$68,622.59 | Worst Trade (Mar 31) -$3.37M | Z-Score 2.49 (98.71%) |
| Commissions $0 | Avg. Trade Length 11m 1w 6d | Expectancy $127,425.55 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 5,495 | 4,945 | 4,396 | 3,846 | 3,297 | 2,747 | 2,198 | 1,648 | 1,099 | 549 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 8,292 | $1.64M | $2.56M | - | $919,169.29 | 55.97% | -7.354% |
ALB Albemarle Corporation | 3,052 | $431,675 | $359,037.28 | - | -$72,637.72 | -16.83% | -0.102% |
AMD Advanced Micro Devices, Inc. | 2,334 | $499,849 | $1.11M | - | $611,485.08 | 122.33% | -1.904% |
AMZN Amazon.com Inc | 3,347 | $556,608.38 | $908,978.23 | - | $352,369.85 | 63.31% | +15.321% |
APH Amphenol Corporation | 5,692 | $277,171.94 | $457,352.2 | - | $180,180.26 | 65.01% | +0.551% |
APP AppLovin Corporation Class A Common Stock | 1,250 | $593,540.52 | $494,874.99 | - | -$98,665.53 | -16.62% | -1.973% |
ASTS AST SpaceMobile, Inc. | 7,244 | $380,898.91 | $427,251.12 | - | $46,352.21 | 12.17% | +0.924% |
AU AngloGold Ashanti plc | 4,263 | $363,549 | $338,141.16 | - | -$25,407.84 | -6.99% | -3.656% |
AVGO Broadcom Inc. | 2,640 | $699,875.62 | $1.03M | - | $327,823.58 | 46.84% | +0.371% |
BIL SPDR Bloomberg 1-3 Month T-Bill ETF | 44,547 | $4.07M | $4.08M | - | $13,363.96 | 0.33% | +0.033% |
BLTE Belite Bio, Inc. | 2,399 | $383,744 | $380,505.39 | - | -$3,238.61 | -0.84% | -0.819% |
BND Vanguard Total Bond Market Index Fund | 259,795 | $19.24M | $18.76M | - | -$478,023.14 | -2.48% | -0.262% |
BNDX Vanguard Total International Bond ETF | 407,361 | $19.68M | $19.46M | - | -$224,049.04 | -1.14% | -0.23% |
BNY BlackRock New York Municipal Income Trust | 3,362 | $284,851.94 | $525,581.46 | - | $240,729.52 | 84.51% | +0.16% |
BRK-B Berkshire Hathaway Inc. | 755 | $277,819.73 | $386,212.7 | - | $108,392.97 | 39.02% | +0.365% |
CAN Canaan Inc. | 463,223 | $319,624.01 | $78,747.91 | - | -$240,876.1 | -75.36% | -30.328% |
CAT Caterpillar Inc. | 757 | $433,663 | $616,811.17 | - | $183,148.17 | 42.23% | +0.701% |
CIEN Ciena Corporation | 1,943 | $454,409 | $732,608.13 | - | $278,199.13 | 61.22% | +1.338% |
COHR Coherent Corp. | 2,388 | $440,753 | $627,781.34 | - | $187,028.34 | 42.43% | +5.553% |
COST Costco Wholesale Corporation | 341 | $267,355.08 | $324,594.49 | - | $57,239.41 | 21.41% | -0.239% |